Logo image of BTLS.BR

BIOTALYS NV (BTLS.BR) Stock Price, Quote, News and Overview

EBR:BTLS - Euronext Brussels - BE0974386188 - Common Stock - Currency: EUR

4.16  +0.16 (+4%)

BTLS.BR Quote, Performance and Key Statistics

BIOTALYS NV

EBR:BTLS (6/4/2025, 7:00:00 PM)

4.16

+0.16 (+4%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustryFertilizers & Agricultural Chemicals
Statistics
52 Week High4.23
52 Week Low2.51
Market Cap155.88M
Shares37.47M
Float19.54M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-02 2021-07-02


BTLS.BR short term performance overview.The bars show the price performance of BTLS.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

BTLS.BR long term performance overview.The bars show the price performance of BTLS.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of BTLS.BR is 4.16 EUR. In the past month the price increased by 29.6%. In the past year, price increased by 38.67%.

BIOTALYS NV / BTLS Daily stock chart

BTLS.BR Competitors/Peers

The largest stocks on the EU markets in the "Fertilizers & Agricultural Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
YAR.OL YARA INTERNATIONAL ASA 14.52 94.79B
SDF.DE K+S AG-REG 1666 2.98B
1SDF.MI K+S AG-REG 49.63 2.84B
OCI.AS OCI NV N/A 1.64B
ALFLO.PA FLORENTAISE SA N/A 7.42M

About BTLS.BR

Company Profile

BTLS logo image Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.

Company Info

BIOTALYS NV

Buchtenstraat 11

Ghent OOST-VLAANDEREN BE

Employees: 75

BTLS Company Website

BTLS Investor Relations

Phone: 3292745400

BIOTALYS NV / BTLS.BR FAQ

What is the stock price of BIOTALYS NV today?

The current stock price of BTLS.BR is 4.16 EUR. The price increased by 4% in the last trading session.


What is the ticker symbol for BIOTALYS NV stock?

The exchange symbol of BIOTALYS NV is BTLS and it is listed on the Euronext Brussels exchange.


On which exchange is BTLS.BR stock listed?

BTLS.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for BIOTALYS NV stock?

8 analysts have analysed BTLS.BR and the average price target is 6.58 EUR. This implies a price increase of 58.15% is expected in the next year compared to the current price of 4.16. Check the BIOTALYS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOTALYS NV worth?

BIOTALYS NV (BTLS.BR) has a market capitalization of 155.88M EUR. This makes BTLS.BR a Micro Cap stock.


How many employees does BIOTALYS NV have?

BIOTALYS NV (BTLS.BR) currently has 75 employees.


What are the support and resistance levels for BIOTALYS NV (BTLS.BR) stock?

BIOTALYS NV (BTLS.BR) has a support level at 3.21. Check the full technical report for a detailed analysis of BTLS.BR support and resistance levels.


Is BIOTALYS NV (BTLS.BR) expected to grow?

The Revenue of BIOTALYS NV (BTLS.BR) is expected to decline by -60% in the next year. Check the estimates tab for more information on the BTLS.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOTALYS NV (BTLS.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOTALYS NV (BTLS.BR) stock pay dividends?

BTLS.BR does not pay a dividend.


What is the Price/Earnings (PE) ratio of BIOTALYS NV (BTLS.BR)?

BIOTALYS NV (BTLS.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).


BTLS.BR Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is one of the better performing stocks in the market, outperforming 96.29% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BTLS.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. The financial health of BTLS.BR is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BTLS.BR Financial Highlights

Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS increased by 38.92% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -35.89%
ROE -47.77%
Debt/Equity 0.13
Chartmill High Growth Momentum
EPS Q2Q%36.42%
Sales Q2Q%N/A
EPS 1Y (TTM)38.92%
Revenue 1Y (TTM)N/A

BTLS.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 88% to BTLS.BR. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -111.84% and a revenue growth -60% for BTLS.BR


Ownership
Inst Owners23.43%
Ins Owners4.85%
Short Float %N/A
Short RatioN/A
Analysts
Analysts87.5
Price Target6.58 (58.17%)
EPS Next Y-111.84%
Revenue Next Year-60%